BHRT and TRT via telehealth: what Oklahoma patients should know

What did @np2go actually say?

Alexa from NPDGo told viewers that yes, hormone replacement therapy, including testosterone, can be handled entirely via telehealth in Oklahoma. Labs get drawn locally, the consultation happens by phone or video, and medications ship to your door. The one exception she named: pellet placement requires an in-person visit. She quoted pricing of $399 for the first month (labs, consult, meds bundled) and $199 monthly after that.

She also flagged something important: "testosterone is a scheduled substance" and can only be prescribed and shipped within Oklahoma state lines. This is not a minor disclaimer. It is the legal backbone of everything she described, and she handled it more honestly than most telehealth hormone ads do.

Does the science back this up?

The telehealth delivery model for TRT is legitimate and increasingly well-studied. A 2022 analysis in The Journal of Urology (Chu et al.) found that telehealth testosterone prescribing increased substantially post-COVID without evidence of worsened clinical outcomes. Remote lab ordering, symptom assessment, and follow-up are all supported in clinical guidelines from the American Urological Association and the Endocrine Society.

The modalities she mentioned, including injections, creams, and oral medications, are all FDA-recognized delivery routes for testosterone in men and women. Oral testosterone undecanoate (Jatenzo, Tlando) received FDA approval for men. Compounded transdermal creams are widely used off-label for women with low androgen levels, though evidence for symptom benefit in women remains more mixed than in men. The Endocrine Society's 2023 guidelines are cautious about routine testosterone use in women outside of carefully documented hypoactive sexual desire disorder.

What did they get wrong (or right)?

Credit where it is due: she correctly identified testosterone as a Schedule III controlled substance under the DEA, which means interstate prescribing and shipping require in-state licensure. Most TRT telehealth ads skip this entirely. She did not.

What she glossed over is the clinical nuance around "getting your hormones balanced." That phrase does real work in hormone marketing, and it deserves scrutiny. There is no universally agreed-upon definition of "balanced" hormones. Reference ranges vary by lab, age, and sex. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) showed testosterone therapy in middle-aged men with hypogonadism did not increase major cardiac events but did raise rates of atrial fibrillation and pulmonary embolism. That is not a reason to avoid TRT, but it is a reason a telehealth consult should include a real cardiovascular risk assessment, not just a lab draw and symptom checklist.

She also listed "oral medications" as a hormone option without specifying which. For women, oral estrogen carries higher VTE risk than transdermal routes. For men, most oral testosterone formulations require fat with meals for absorption. These are not trivial details to leave out of a public-facing video.

What should you actually know?

If you are in Oklahoma and considering hormone therapy via telehealth, the model NPDGo describes is legally plausible and clinically workable, but the $399 entry price is only meaningful if the consultation is thorough enough to catch contraindications. That means asking about cardiovascular history, clotting risk, sleep apnea, and prostate health for men, not just symptoms of fatigue or low libido.

Telehealth TRT platforms vary enormously in prescribing standards. A 2021 study in JAMA Internal Medicine (Jasuja et al.) found that testosterone prescribing without documented hypogonadism diagnosis is common and problematic. Ask your provider which diagnostic criteria they use before any prescription is written.

• BHRT pellets, which she mentioned as the one in-office requirement, carry specific risks including infection, pellet extrusion, and difficulty titrating doses once implanted. The North American Menopause Society notes pellets are not FDA-approved for hormone therapy.
• "Feeling better" after starting hormones may reflect placebo response, lifestyle changes, or actual hormonal correction. Baseline and follow-up labs matter for distinguishing these.

Is a $399 telehealth hormone visit a good deal?

Compared to cash-pay endocrinology or gynecology visits, the bundled pricing is competitive. Hormone panels at direct-to-consumer lab services like LabCorp or Quest can run $150 to $300 alone. The math is not unreasonable if the clinical quality is there.

The risk with membership-based hormone clinics is that the business model favors retention, not necessarily reassessment. If your labs normalize and your symptoms resolve, will the platform recommend stopping or reducing therapy? That question is worth asking before you sign up for month two at $199.